ST華鼎(601113.SH):控股股東持有的約3.1256億股新增兩輪輪候凍結
格隆匯12月30日丨ST華鼎(601113.SH)公佈,公司於近日收到中國證券登記結算有限責任公司上海分公司《股權司法凍結及司法劃轉通知》(2019司凍1227-02號),獲悉公司控股股東三鼎控股集團有限公司(“三鼎控股”)持有的公司無限售流通股312,557,900股新增兩輪輪候凍結。具體情況如下:
本次股份被凍結基本情況:

截至公告披露日,控股股東累計被凍結股份情況如下:

截至目前,三鼎控股發行的債券“17三鼎01”、“17三鼎02”、“17三鼎03”、“17三鼎04”共計20億元因未能按期足額兑付本息,已構成實質性違約。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.